#GluSense gets funding for #implantable #biosensor it says could be a year-long CGM
By Jonah Comstock February 15, 2017 GluSense, an Israeli medical device company, announced an undisclosed investment from the JDRF T1D Fund, a recently launched VC philanthropy fund dedicated to funding early stage programs for Type 1 diabetes. GluSense is being incubated in the Rainbow Medical innovation house, a private investment company that seeds and grows medical [...]